Ketamine HCl Injection, USP, 50 mg/1 mL (50 mg/mL*) syringe, packaged in 5 x 1 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-511-01
Published July 27, 2022 · Recall initiated: June 30, 2022
Summary
FDA records drug Class II recall D-1261-2022, published July 27, 2022 and initiated June 30, 2022. Recalling firm: Nephron Sterile Compounding Center LLC; Status: Terminated; Reported quantity: 47,905 syringes; Lot: Lots: KH2009A, Exp. 8/16/2022; KH2011A, Exp. 8/24/2022; KH2013A, Exp. 8/28/2022; KH2014A, Exp. 9/9/2022; KH2018A, Exp. 10/7/2022; KH2020A, Exp. 10/18/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Distributor
- Nationwide in the USA
- Lot
- Lots: KH2009A, Exp. 8/16/2022; KH2011A, Exp. 8/24/2022; KH2013A, Exp. 8/28/2022; KH2014A, Exp. 9/9/2022; KH2018A, Exp. 10/7/2022; KH2020A, Exp. 10/18/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility,March 19, 2025
- FDAPhenylephrine HCl in 0.9% Sodium Chloride Injection, USP, 50 mg/250 mL (200 mcg/mL), 250 mL Single-DoseMarch 8, 2023
- FDANorepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 16 mg/250 mL (64 mcg/mL*), 250 mLMarch 8, 2023
- FDAPhenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mLMarch 8, 2023
- FDAKetamine HCl Injection, USP 30 mg/3 mL (10 mg/mL*) syringes, packaged in 5 x 3 mL Pre-Filled Syringes perJuly 27, 2022
- FDALabetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL) syringe, packaged in 5 x 4 mL Pre-Filled Syringes perJuly 27, 2022
Questions about this recall
Was Ketamine HCl Injection, USP, 50 mg/1 mL (50 mg/mL*) syringe, packaged in 5 x 1 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-511-01 recalled?
Yes. FDA published recall D-1261-2022 on July 27, 2022. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter